How Much of the Problem of Generic Drug Bioequivalence Is Due to Indian Manufacturing?

Executive Summary

  • Bioequivalence is the similarity of a generic drug to the original.
  • Generics have a known issue with bioequivalence that is often discussed separately from the topic of Indian manufacturing.


Two issues that deeply intersect but are not discussed in unison are the significant variance between generics and the original drug and how India manufactures around 40% of all generics (and growing) and has, on average, poor quality in their drugs matching the original.

Wait One Second...

Why is The Article Not Viewable?

You are seeing this text instead of the article because of two potential reasons.

Reason #1: You are a Subscriber but Not Signed In

You can sign in by simply sending yourself a link to the email you signed in with by going here.

It's as easy as 1,2,3.  

You can read any article on the site as soon as you sign in.

Reason #2: You Are Not Yet Subscribed to the Site

This is a subscription site. That is how we pay for the research we do. We have to charge subscribers to access articles because, unlike WebMD, Healthline, or the Mayo Clinic, we don't allow pharmaceutical companies to write or edit our articles. 

You can access this and many other articles by becoming a subscriber.

How Do You Subscribe?

See the following article, which explains what you get with a subscription Subscribe to the Site.

You can be reading this article and many others like it in just a few minutes from now.